Liver-specific knock-out of IRS1 and IRS2 prevents activation of the pathway in response to insulin, leading to insulin resistance and hyperglycemia, but not hepatic steatosis (Dong et al. 2008, Kubota et al. 2016). This evidence concerns the gene INS and Hyperglycemia.